drugset / Trial / NCT06156059

Oral Bedtime Melatonin in Critically Ill Patients

NCT06156059

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Oxidative stress is one of the main mechanisms causing harm in severe infection with septic shock, ischemia-reperfusion injury in resuscitated cardiac arrest and ischemic and hemorrhagic stroke. Melatonin is a potent scavenger of the mediators of oxidative stress, oxygen and nitrogen-reactive species, which directly injure cell structures like walls and DNA and thus cause organ dysfunction. In a previous study we have observed that high-dose oral bedtime melatonin (OBM) is associated with improved organ function in severe Covid-19 patients

Timeline

Start
2025-02-01
Primary completion
2026-02-01
Completion
2026-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Melatonin Small molecule 100 mg Oral